PT1197485E - Derivados de ciclobuteno-diona e a sua utilizacao no tratamento da aterosclerose - Google Patents

Derivados de ciclobuteno-diona e a sua utilizacao no tratamento da aterosclerose

Info

Publication number
PT1197485E
PT1197485E PT01402623T PT01402623T PT1197485E PT 1197485 E PT1197485 E PT 1197485E PT 01402623 T PT01402623 T PT 01402623T PT 01402623 T PT01402623 T PT 01402623T PT 1197485 E PT1197485 E PT 1197485E
Authority
PT
Portugal
Prior art keywords
bond
optionally substituted
alkyl
cytobuteno
aterosclerosis
Prior art date
Application number
PT01402623T
Other languages
English (en)
Inventor
Jean-Louis Peglion
Jean-Paul Vilaine
Catherine Thollon
Nicole Villeneuve
Marie-Pierre Bourguignon
Christophe Poitevin
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of PT1197485E publication Critical patent/PT1197485E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT01402623T 2000-10-12 2001-10-11 Derivados de ciclobuteno-diona e a sua utilizacao no tratamento da aterosclerose PT1197485E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0013072A FR2815345B1 (fr) 2000-10-12 2000-10-12 Nouveaux derives de cyclobutene-dione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
PT1197485E true PT1197485E (pt) 2004-10-29

Family

ID=8855275

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01402623T PT1197485E (pt) 2000-10-12 2001-10-11 Derivados de ciclobuteno-diona e a sua utilizacao no tratamento da aterosclerose

Country Status (25)

Country Link
US (1) US6696469B2 (pt)
EP (1) EP1197485B1 (pt)
JP (1) JP3566685B2 (pt)
KR (1) KR100511132B1 (pt)
CN (1) CN1274675C (pt)
AR (1) AR033683A1 (pt)
AT (1) ATE273276T1 (pt)
AU (1) AU781002B2 (pt)
BR (1) BR0104471A (pt)
CA (1) CA2358724C (pt)
DE (1) DE60104791T2 (pt)
DK (1) DK1197485T3 (pt)
EA (1) EA004268B1 (pt)
ES (1) ES2227092T3 (pt)
FR (1) FR2815345B1 (pt)
HK (1) HK1045517B (pt)
HU (1) HUP0104272A3 (pt)
MX (1) MXPA01010049A (pt)
NO (1) NO320702B1 (pt)
NZ (1) NZ514758A (pt)
PL (1) PL350104A1 (pt)
PT (1) PT1197485E (pt)
SI (1) SI1197485T1 (pt)
TR (1) TR200402070T4 (pt)
ZA (1) ZA200108404B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006009734A1 (en) 2004-06-17 2006-01-26 Wyeth Gonadotropin releasing hormone receptor antagonists
NZ552093A (en) 2004-06-17 2009-06-26 Wyeth Corp Processes for preparing gonadotropin releasing hormone receptor antagonists
WO2006058012A2 (en) * 2004-11-23 2006-06-01 Wyeth Gonadotropin releasing hormone receptor antagonists
ES2327840T3 (es) * 2004-12-23 2009-11-04 Gpc Biotech Ag Derivados de acido escuarico con actividad antiproliferativa.
US7538113B2 (en) 2005-02-18 2009-05-26 Wyeth 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7534796B2 (en) 2005-02-18 2009-05-19 Wyeth Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US7582634B2 (en) 2005-02-18 2009-09-01 Wyeth 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US20060189619A1 (en) * 2005-02-24 2006-08-24 Wyeth 3-({4-[2-(4-Tert-butylphenyl)-1h-benzimidazol-4-yl]piperazin-1-yl}methyl)pyrido[2,3-b]]pyrazi ne compounds
US7531542B2 (en) 2005-05-18 2009-05-12 Wyeth Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en) 2005-05-26 2009-09-01 Wyeth Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
US8450348B2 (en) * 2007-02-21 2013-05-28 Forma Tm, Llc Derivatives of squaric acid with anti-proliferative activity
EP2318369A1 (en) 2008-06-24 2011-05-11 TopoTarget A/S Squaric acid derivatives as inhibitors of the nicotinamide
EP2760821B1 (en) 2011-09-02 2017-10-11 Novartis AG Choline salt of an anti-inflammatory substituted cyclobutenedione compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1105377B1 (en) * 1998-08-21 2003-10-08 SmithKline Beecham plc Pyrimidinone derivatives for the treatment of atherosclerosis
BR9916211A (pt) * 1998-12-14 2001-09-11 American Home Prod Derivados de 3,4-diamino-3-ciclobuteno-1,2-diona que inibem adesão de leucócito mediada por vla-4
US6432960B2 (en) * 2000-05-10 2002-08-13 Bristol-Myers Squibb Company Squarate derivatives of dihydropyridine NPY antagonists

Also Published As

Publication number Publication date
ES2227092T3 (es) 2005-04-01
DK1197485T3 (da) 2004-11-29
CA2358724A1 (fr) 2002-04-12
HU0104272D0 (en) 2001-12-28
NO20014945D0 (no) 2001-10-11
KR20020029319A (ko) 2002-04-18
CN1274675C (zh) 2006-09-13
MXPA01010049A (es) 2002-04-22
TR200402070T4 (tr) 2004-09-21
DE60104791T2 (de) 2005-08-18
HUP0104272A3 (en) 2004-01-28
JP2002193932A (ja) 2002-07-10
HK1045517B (zh) 2007-03-23
US6696469B2 (en) 2004-02-24
CN1347875A (zh) 2002-05-08
BR0104471A (pt) 2002-05-28
EP1197485B1 (fr) 2004-08-11
US20020065419A1 (en) 2002-05-30
AU7938601A (en) 2002-05-02
ZA200108404B (en) 2002-06-05
AU781002B2 (en) 2005-04-28
FR2815345A1 (fr) 2002-04-19
PL350104A1 (en) 2002-04-22
ATE273276T1 (de) 2004-08-15
SI1197485T1 (en) 2004-12-31
KR100511132B1 (ko) 2005-08-31
NO320702B1 (no) 2006-01-16
EP1197485A1 (fr) 2002-04-17
EA200100969A1 (ru) 2002-04-25
NZ514758A (en) 2002-09-27
NO20014945L (no) 2002-04-15
EA004268B1 (ru) 2004-02-26
DE60104791D1 (de) 2004-09-16
JP3566685B2 (ja) 2004-09-15
FR2815345B1 (fr) 2002-12-13
AR033683A1 (es) 2004-01-07
HUP0104272A2 (hu) 2002-07-29
HK1045517A1 (pt) 2002-11-29
CA2358724C (fr) 2005-09-13

Similar Documents

Publication Publication Date Title
ATE275134T1 (de) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
PT1197485E (pt) Derivados de ciclobuteno-diona e a sua utilizacao no tratamento da aterosclerose
HUP9802822A2 (hu) Halogén-benzimidazol-származékok, intermedierjeik, előállításuk és a vegyületeket hatóanyagként tartalmazó mikrobicid készítmények
CZ83996A3 (en) Hydroxy substituted azetidine compounds and their use as hypocholesterol agents
CO5670367A2 (es) Derivados de acido fenoxiacetico
DK0447285T3 (da) Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
HUP0301857A2 (hu) 3(5)-Ureido-pirazol-származékok, eljárás elżállításukra alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
EA200401056A1 (ru) Комбинация, содержащая производные тропана, полезные в терапии
ES2114645T3 (es) Utilizacion de un fosfato de alfa-tocoferol, o de uno de sus derivados para la preparacion de una composicion cosmetica, dermatologica o farmaceutica, de actividad anti-radicalar; composicion asi obtenida.
DE60124504D1 (de) Stabile emulsionszubereitungen
PE20030549A1 (es) Derivados de 1,6-naftiridina y su uso para el tratamiento de la diabetes y transtornos relacionados
HUP0400558A2 (hu) Helyettesített benzolszármazékok, illetve sóik és ezeket tartalmazó gyógyszerkészítmények
PT992509E (pt) Novos derivados macrolidos
DK0656015T3 (da) Nye inklusionskomplekser af nimesulidsalt med cyclodextrin
DK0843967T3 (da) Anvendelse af beta-aminopripionsyrederivater som fungicider
AR036176A1 (es) Un derivado de fenil-acetamido-tiazol, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un producto o kit que los comprende, y un metodo que utiliza dicho derivado
DK0428442T3 (da) Midler og farvningsfremgangsmåder, hvori anvendes derivater af 6- eller 7-hydroxyindol som koblere
FR2658510B1 (fr) Nouveau derive de la beta-phenylisoserine, sa preparation et son emploi.
DK1219621T3 (da) Azaindolizinonderivater og cerebral funktionsforbedrende midler indeholdende disse som den aktive bestanddel
ATE115135T1 (de) Pollen unterdrückendes mittel, das 5-oxy- oder - amino-substituiertes cinnolin enthält.
ATE204278T1 (de) Serotoninergische ergolin derivate
FI905883A0 (fi) Röntgenvarjoaineina käyttökelpoisia 5-amino-2,4,6-trijodi-1,3-bentseenidikarboksiamidojohdannaisia ja menetelmä niiden valmistamiseksi
DE69023939D1 (de) Förderung der Osteogenese durch Verwendung von Vitamin D-Derivaten.
HUP0203937A2 (hu) 2,5-Diaminopiridin oxidációs bázisok, ezeket tartalmazó keratinszálak festésére szolgáló festékkészítmények és eljárás keratinszálak festésére
ATE160566T1 (de) Amphotere tricyclische verbindungen als antihistaminische und antiallergische mittel